Avinger (NASDAQ:AVGR) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Avinger (NASDAQ:AVGR) in a research report sent to investors on Sunday morning. The brokerage issued a hold rating on the medical device company’s stock.

Avinger Stock Performance

NASDAQ:AVGR opened at $0.47 on Friday. Avinger has a 1 year low of $0.36 and a 1 year high of $4.37. The stock has a market cap of $1.57 million, a price-to-earnings ratio of -0.04 and a beta of 1.09. The stock has a 50-day moving average price of $0.63 and a two-hundred day moving average price of $0.82.

About Avinger

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.